Related Experiment Video
Updated: May 27, 2026

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size (LEfSe) in Microbiome Data
Published on: May 16, 2022
Bayesian Sparse Regression for Microbiome-Metabolite Data Integration
Kai Jiang1,2, Satabdi Saha2, Christine B Peterson3
1Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
This study introduces a new Bayesian method to analyze gut microbial metabolites and microbiome data, crucial for understanding cancer risk and treatment. The method effectively handles missing data and compositional effects, improving cancer research insights.
Area of Science:
- Microbiome research
- Metabolomics
- Cancer biology
Background:
- Microbial metabolites influence cancer risk and treatment response.
- Metabolite data often has missing values due to low abundance or technical issues.
- Microbiome data is compositional, limiting standard analysis methods.
Purpose of the Study:
- To develop a novel Bayesian regression method for integrating gut microbiome and metabolite data.
- To address challenges of missing metabolite data and compositional microbiome data.
- To improve the understanding of the microbiome-metabolome interplay in cancer.
Main Methods:
- A novel Bayesian regression model was proposed.
- The model accounts for two missingness mechanisms in metabolite data.
- A Bayesian prior was designed for compositional microbiome data.
Main Results:
- The proposed model accurately imputes unobserved metabolite values on simulated data.
- The model correctly identifies relevant microbiome predictors.
- The method was successfully applied to real colorectal cancer data.
Conclusions:
- The developed Bayesian method effectively integrates microbiome and metabolite data.
- This approach can improve the analysis of complex biological data in cancer research.
- It offers a robust framework for studying microbiome-metabolome interactions in disease.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Methods to Assess Microbial Communities
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Biostatistics: Overview
Discrete variables are...
Methods to Assess Microbial Populations
